OM
NXTC icon

Opaleye Management’s NextCure NXTC Stock Holding History

Opaleye Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.51M Buy
+141,181
New +$1.72M 0.2% 48
2019
Q4 		– Sell
-7,083
Closed -$2.62M – 50
2019
Q3 		$2.62M Buy
+7,083
New +$2.3M 0.95% 36

Other funds holding NXTC

SCM
Squadron Capital Management Westmont, Illinois $273M AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Opaleye Management's NXTC Position: Q1 2026 in Review

Opaleye Management opened a new position in NextCure (NXTC) in Q1 2026: 141,181 shares worth $1.51M. The stake represents 0.2% of the portfolio and ranks #48 among its holdings. This is a return to the name: Opaleye Management previously reported a position in NXTC as recently as Q3 2019.

Opaleye Management first reported a position in NXTC in Q3 2019 and has held it in 2 quarters since. The position peaked at $2.62M in Q3 2019. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

  • Opaleye Management held 141,181 shares of NextCure worth $1.51M as of Q1 2026.
  • NextCure was a new Opaleye Management position in Q1 2026.
  • NextCure made up 0.2% of Opaleye Management's portfolio in Q1 2026, its #48 holding.
  • Opaleye Management first reported a position in NextCure in Q3 2019 and has held it in 2 quarters since.
  • Opaleye Management's NextCure position peaked at $2.62M in Q3 2019.
  • 26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on Opaleye Management's 13F filing for Q1 2026, filed 15 May 2026.